Related Experiment Video
Updated: May 9, 2026
11:44
Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
Published on: October 2, 2018
Re-engineering the μ-conotoxin SIIIA scaffold
K B Akondi1, R J Lewis, P F Alewood
1Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, 4072, Queensland, Australia.
Biopolymers
|August 6, 2013
Summary
Researchers modified µ-Conotoxin SIIIA to create potent blockers for voltage-gated sodium (Nav) 1.2 channels, offering potential for new neuropathic pain therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Voltage-gated sodium (Nav) channels are crucial for nerve impulse transmission.
- Nav channel dysfunction is linked to disorders like neuropathic pain.
- Targeted Nav channel blockers are needed for therapeutic development.
Purpose of the Study:
- To reengineer µ-Conotoxin SIIIA (a Nav 1.2 blocker) to develop novel mimetics with altered selectivity.
- To investigate the role of SIIIA loop 1 in Nav channel interactions.
Main Methods:
- Site-directed mutagenesis was used to alter charges and truncate loop 1 of µ-Conotoxin SIIIA.
- The potency and selectivity of engineered mutants against Nav channels were assessed.
Main Results:
- A mutant, [N5K/D15A]SIIIA(3-20), showed significantly enhanced potency against Nav 1.2 channels (0.5 nM IC50).
- Modifications in loop 1 unexpectedly influenced SIIIA's interaction with Nav channels.
- Further truncations resulted in a loss of potency.
Conclusions:
- Loop 1 of SIIIA plays a significant role in Nav channel interactions, contrary to previous assumptions.
- A minimal functional conotoxin scaffold was identified, paving the way for developing selective Nav channel blockers.
- These findings could lead to new treatments for conditions like neuropathic pain.
